News Releases

Brightseed Receives $1.6 Million Grant to Improve Birth Outcomes

The bioactives company will build upon a proof-of-concept program with grant funding from the Bill & Melinda Gates Foundation

Company Logo

Released By Brightseed

SAN FRANCISCO–(BUSINESS WIRE)–Bioactives company Brightseed today announces its second grant from the Bill & Melinda Gates Foundation. Brightseed will use the $1.6 million funding to focus its artificial intelligence (AI) technology, Forager®, on identifying and validating natural bioactive compounds that target environmental enteric dysfunction (EED) in undernourished pregnant and lactating women, ultimately impacting global birth and infant outcomes.
 
EED is a poorly understood condition caused in part by micronutrient deficiencies, undernutrition, certain gut infections, and abnormal gut microbiota. While EED is usually asymptomatic, in infants it is associated with nutrient malabsorption, stunting, and wasting, which can have long-term effects on the health and development of affected children.

READ ON…

Request more information from Brightseed

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Related Library